Description
CMV – CI combi r.t.u. antigen contains native CMV proteins (lysate from human cells infected by the virus) and a mixture of immunoactive peptides derived from immunodominant CMV proteins pp65 and IE1. It is intended for the specific stimulation of CD4+ and CD8+ T-lymphocytes.